Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to 12.25%.

  • Mesa Laboratories' EBIT Margin rose 30500.0% to 12.25% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.96%, marking a year-over-year increase of 1148100.0%. This contributed to the annual value of 6.78% for FY2025, which is 1326300.0% up from last year.
  • As of Q4 2025, Mesa Laboratories' EBIT Margin stood at 12.25%, which was up 30500.0% from 7.78% recorded in Q3 2025.
  • Mesa Laboratories' EBIT Margin's 5-year high stood at 12.25% during Q4 2025, with a 5-year trough of 460.55% in Q1 2024.
  • Moreover, its 5-year median value for EBIT Margin was 5.61% (2024), whereas its average is 18.88%.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -4614800bps in 2024, then soared by 4629200bps in 2025.
  • Quarter analysis of 5 years shows Mesa Laboratories' EBIT Margin stood at 4.59% in 2021, then soared by 236bps to 6.27% in 2022, then crashed by -102bps to 0.13% in 2023, then soared by 7440bps to 9.2% in 2024, then skyrocketed by 33bps to 12.25% in 2025.
  • Its EBIT Margin was 12.25% in Q4 2025, compared to 7.78% in Q3 2025 and 5.15% in Q2 2025.